CON# IDIQ-HHS-PEIEB-15
    Sponsoring Agency HHS
    POP 9/20/12 - 9/19/14 (1 year)

Description

Master IDIQ for evaluating the efficacy of potential chemopreventive regimens as well as to identifypharmacodynamic and or efficacy biomarkers which will enhance the development of these regimens for clinicaltrials.

  • $9.6m Aggregate Dollars Obligated
  • $9.6m Aggregate Base & Exercised Options
  • $9.6m Aggregate Base & All Options (Ceiling)

Market Stats Related Contracts